Our results, for the first time, demonstrated that exogenous TGM3 expression could exert strong anti-proliferative effects on HNSCC cell lines in vitro and decreased tumorigenicity in vivo. This evidence concerns the gene TGM3 and head and neck squamous cell carcinoma.